165 filings
Page 8 of 9
6-K
9l1lejg1t6wg4x3mu
25 Nov 16
Current report (foreign)
12:00am
6-K
6bhzo
21 Nov 16
ESSA Secures US$10 Million Term Loan from Silicon Valley Bank
12:00am
6-K
vsdaqth2jom3tg1e12
12 Sep 16
ESSA Pharma to present at Rodman & Renshaw 18th Annual Global Investment Conference
12:00am
6-K
nftwl88oelgr6v
12 Aug 16
Condensed Consolidated Interim Financial Statements
12:00am
6-K
optbnibjnz 2wgz5p2
8 Aug 16
Current report (foreign)
12:00am
6-K
csjf1n0p1q3v9x9l6h
1 Aug 16
ESSA Names Peter Virsik as Executive Vice President & Chief Operating Officer
12:00am
6-K
wb80kfwy7ohev44
13 May 16
Condensed Consolidated Interim Financial Statements
12:00am
6-K
yt684nkl
15 Apr 16
Current report (foreign)
12:00am
6-K
tzgd5v
31 Mar 16
Form 51-102F3 Material Change Report
12:00am
6-K
r21w nhkq
22 Mar 16
ESSA Pharma Announces Closing of US$5 Million Private Placement
12:00am
6-K
f2273ca 1w5vn0681
11 Mar 16
ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of Shareholders
12:00am
6-K
e7lk0
16 Feb 16
Condensed Consolidated Interim Financial Statements
12:00am
6-K
f0tgj17965wc
19 Jan 16
Form 51-102F3 Material Change Report
12:00am
6-K
ksmurv
15 Jan 16
ESSA PHARMA ANNOUNCES CLOSING OF US$15 MILLION PRIVATEPlacement
12:00am
6-K
87ipm7njc 4ush5
15 Jan 16
Current report (foreign)
12:00am
6-K
2rja f88u
7 Jan 16
ESSA Pharma Announces Senior Leadership Changes
12:00am
6-K
brni5lec40
6 Jan 16
Essa Pharma Announces Proposed US$15 Million Private Placement
12:00am
6-K
p433 mtzkbqwt53v0t
16 Dec 15
Essa Pharma Announces Filing of Preliminary Shelf Prospectus and Registration Statement
12:00am
6-K
atuuk0 xg8odsfln5w
15 Dec 15
Current report (foreign)
12:00am
6-K
hwqkf
25 Nov 15
ESSA Announces Enrollment of First Patient in Phase 1/2 Trial
12:00am